INDP
Price
$11.64
Change
+$1.34 (+13.01%)
Updated
Jun 27 closing price
Capitalization
6.67M
49 days until earnings call
ISCO
Price
$0.16
Change
-$0.00 (-0.00%)
Updated
Jun 26 closing price
Capitalization
1.26M
Interact to see
Advertisement

INDP vs ISCO

Header iconINDP vs ISCO Comparison
Open Charts INDP vs ISCOBanner chart's image
Indaptus Therapeutics
Price$11.64
Change+$1.34 (+13.01%)
Volume$41.48K
Capitalization6.67M
International Stem Cell
Price$0.16
Change-$0.00 (-0.00%)
Volume$11.99K
Capitalization1.26M
INDP vs ISCO Comparison Chart in %
Loading...
INDP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ISCO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INDP vs. ISCO commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INDP is a Buy and ISCO is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (INDP: $11.64 vs. ISCO: $0.16)
Brand notoriety: INDP and ISCO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INDP: 13% vs. ISCO: 205%
Market capitalization -- INDP: $6.67M vs. ISCO: $1.26M
INDP [@Biotechnology] is valued at $6.67M. ISCO’s [@Biotechnology] market capitalization is $1.26M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INDP’s FA Score shows that 1 FA rating(s) are green whileISCO’s FA Score has 1 green FA rating(s).

  • INDP’s FA Score: 1 green, 4 red.
  • ISCO’s FA Score: 1 green, 4 red.
According to our system of comparison, ISCO is a better buy in the long-term than INDP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INDP’s TA Score shows that 6 TA indicator(s) are bullish while ISCO’s TA Score has 4 bullish TA indicator(s).

  • INDP’s TA Score: 6 bullish, 3 bearish.
  • ISCO’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, INDP is a better buy in the short-term than ISCO.

Price Growth

INDP (@Biotechnology) experienced а +53.91% price change this week, while ISCO (@Biotechnology) price change was +4.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

INDP is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INDP($6.67M) has a higher market cap than ISCO($1.26M). ISCO YTD gains are higher at: 92.989 vs. INDP (-50.634). INDP has less debt than ISCO: INDP (59.5K) vs ISCO (4.1M).
INDPISCOINDP / ISCO
Capitalization6.67M1.26M531%
EBITDAN/A111K-
Gain YTD-50.63492.989-54%
P/E RatioN/AN/A-
RevenueN/A9.09M-
Total CashN/A1.45M-
Total Debt59.5K4.1M1%
FUNDAMENTALS RATINGS
INDP vs ISCO: Fundamental Ratings
INDP
ISCO
OUTLOOK RATING
1..100
9892
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
5
Undervalued
PROFIT vs RISK RATING
1..100
98100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6440
P/E GROWTH RATING
1..100
10090
SEASONALITY SCORE
1..100
4985

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ISCO's Valuation (5) in the null industry is in the same range as INDP (32). This means that ISCO’s stock grew similarly to INDP’s over the last 12 months.

INDP's Profit vs Risk Rating (98) in the null industry is in the same range as ISCO (100). This means that INDP’s stock grew similarly to ISCO’s over the last 12 months.

INDP's SMR Rating (100) in the null industry is in the same range as ISCO (100). This means that INDP’s stock grew similarly to ISCO’s over the last 12 months.

ISCO's Price Growth Rating (40) in the null industry is in the same range as INDP (64). This means that ISCO’s stock grew similarly to INDP’s over the last 12 months.

ISCO's P/E Growth Rating (90) in the null industry is in the same range as INDP (100). This means that ISCO’s stock grew similarly to INDP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INDPISCO
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
82%
MACD
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
73%
Advances
ODDS (%)
Bullish Trend 13 days ago
79%
N/A
Declines
ODDS (%)
Bearish Trend 15 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
INDP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ISCO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PDM7.280.18
+2.54%
Piedmont Realty Trust Inc
CGTX0.30N/A
N/A
Cognition Therapeutics
FANG139.77-1.10
-0.78%
Diamondback Energy
STNG40.42-0.50
-1.22%
Scorpio Tankers
HBIO0.46-0.05
-9.44%
Harvard Bioscience

INDP and

Correlation & Price change

A.I.dvisor indicates that over the last year, INDP has been loosely correlated with UNCY. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if INDP jumps, then UNCY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INDP
1D Price
Change %
INDP100%
+3063.04%
UNCY - INDP
52%
Loosely correlated
+14.48%
CDTX - INDP
40%
Loosely correlated
+2.96%
COYA - INDP
25%
Poorly correlated
-0.85%
ISCO - INDP
25%
Poorly correlated
N/A
NUVB - INDP
25%
Poorly correlated
-2.54%
More

ISCO and

Correlation & Price change

A.I.dvisor tells us that ISCO and XBIT have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ISCO and XBIT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ISCO
1D Price
Change %
ISCO100%
N/A
XBIT - ISCO
29%
Poorly correlated
-2.44%
INDP - ISCO
22%
Poorly correlated
+3063.04%
CORT - ISCO
21%
Poorly correlated
-1.49%
BLTE - ISCO
20%
Poorly correlated
-1.44%
IGXT - ISCO
9%
Poorly correlated
N/A
More